A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation

Transplantation

Volumn 91, Issue 1, 2011, Pages 48-56

  Hall, Isaac E ^a   Doshi, Mona D ^b   Poggio, Emilio D ^c   Parikh, Chirag R ^a  

^a YALE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Delayed graft function; Kidney transplantation; Serum cystatin C; Serum IL 18; Serum NGAL

Indexed keywords

CREATININE; CYSTATIN C; INTERLEUKIN 18; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; FEMALE; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; DELAYED GRAFT FUNCTION; FEMALE; HUMANS; INTERLEUKIN-18; KIDNEY; KIDNEY TRANSPLANTATION; LIPOCALINS; MALE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RENAL DIALYSIS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78751662129     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fc4b3a     Document Type: Article

References (52)

1. Humar A, Ramcharan T, Kandaswamy R, et al. Risk factors for slow graft function after kidney transplants: A multivariate analysis. Clin Transplant 2002;16:425.
2. Johnston O, O'Kelly P, Spencer S, et al. Reduced graft function (with or without dialysis) vs immediate graft function-A comparison of longterm renal allograft survival. Nephrol Dial Transplant 2006;21:2270.
3. Rodrigo E, Ruiz JC, Pinera C, et al. Creatinine reduction ratio on posttransplant day two as criterion in defining delayed graft function. Am J Transplant 2004;4:1163.
4. Yarlagadda SG, Coca SG, Formica RN Jr, et al. Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 2009;24:1039.
5. Almond PS, Troppmann C, Escobar F, et al. Economic impact of delayed graft function. Transplant Proc 1991;23(1 pt 2):1304.
6. Rosenthal JT, Danovitch GM, Wilkinson A, et al. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991;51:1115.
7. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 1985;27:928.
8. Kottgen A, Selvin E, Stevens LA, et al. Serum cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2008;51:385.
9. Premaratne E, MacIsaac RJ, Finch S, et al. Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 2008;31:971.
10. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3, 418 individuals with CKD. Am J Kidney Dis 2008;51:395.
11. Poge U, Gerhardt T, Woitas RP. Equations to estimate GFR using serum cystatin C in kidney transplant recipients. Am J Kidney Dis 2008;52:383.
12. Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 1999;14:1991.
13. White C, Akbari A, Hussain N, et al. Estimating glomerular filtration rate in kidney transplantation: A comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005;16:3763.
14. Herget-Rosenthal S, Trabold S, Huesing J, et al. Cystatin C-An accurate marker of glomerular filtration rate after renal transplantation? Transpl Int 2000;13:285.
15. Benohr P, Grenz A, Hartmann JT, et al. Cystatin C-A marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res 2006;29:32.
16. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115.
17. Stabuc B, Vrhovec L, Stabuc-Silih M, et al. Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy. Clin Chem 2000;46:193.
18. Villa P, Jiménez M, Soriano MC, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients [see comment]. Critical Care 2005;9: R139.
19. Zhu J, Yin R, Wu H, et al. Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass. Clin Chim Acta 2006;374:116.
20. Rickli H, Benou K, Ammann P, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 2004;61:98.
21. Ahlstrom A, Tallgren M, Peltonen S, et al. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004;62:344.
22. Mazul-Sunko B, Zarkovic N, Vrkic N, et al. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients. Nephron Clin Pract 2004;97: c103.
23. Perianayagam MC, Seabra VF, Tighiouart H, et al. Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: A comparative study. Am J Kidney Dis 2009;54:1025.
24. Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009;20:2625.
25. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049.
26. Bokenkamp A, Domanetzki M, Zinck R, et al. Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem 1999;45:1866.
27. Leach TD, Kitiyakara C, Price CP, et al. Prognostic significance of serum cystatin c concentrations in renal transplant recipients: 5-year follow-up. Transplant Proc 2002;34:1152.
28. Plebani M, Dall'Amico R, Mussap M, et al. Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? Apreliminary study on renal transplant patients. Ren Fail 1998;20:303.
29. Thervet E, Le Bricon T, Hugot V, et al. Early diagnosis of renal function recovery by cystatin C in renal allograft recipients. Transplant Proc 2000;32:2779.
30. Bökenkamp A, Ozden N, Dieterich C, et al. Cystatin C and creatinine after successful kidney transplantation in children. Clin Nephrol 1999;52:371.
31. Christensson A, Ekberg J, Grubb A, et al. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol 2003;94: p19.
32. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 2008;73:1008.
33. Constantin JM, Futier E, Perbet S, et al. Plasma neutrophil gelatinaseas-sociated lipocalin is an early marker of acute kidney injury in adult critically ill patients: A prospective study. J Crit Care 2009;25:176e1.
34. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-A prospective cohort study. Crit Care Med 2009;37:553.
35. Hall IE, Yarlagadda SG, Coca SG, et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010;21:189.
36. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006;6:1639.
37. Herget-Rosenthal S, Pietruck F, Volbracht L, et al. Serum cystatin C-A superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol 2005;64:41.
38. Geramizadeh B, Azarpira N, Ayatollahi M, et al. Value of serum cystatin C as a marker of renal function in the early post kidney transplant period. Saudi J Kidney Dis Transpl 2009;20:1015.
39. Mendiluce A, Bustamante J, Martin D, et al. Cystatin C as a marker of renal function in kidney transplant patients. Transplant Proc 2005;37:3844.
40. Risch L, Herklotz R, Blumberg A, et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001;47:2055.
41. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995;55:617.
42. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinasea-ssociated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012.
43. Araki S, Haneda M, Koya D, et al. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: An observational follow-up study. Diabetologia 2007;50:867.
44. Calvani N, Richards HB, Tucci M, et al. Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin Exp Immunol 2004;138:171.
45. Al-Malki N, Heidenheim PA, Filler G, et al. Cystatin C levels in functionally anephric patients undergoing dialysis: The effect of different methods and intensities. Clin J Am Soc Nephrol 2009;4:1606.
46. Chiang CK, Huang JW, Hsu SP, et al. Plasma interleukin-18 levels in hemodialysis patients: Increased by dialysis process and association with interleukin-6 and tumor necrotic factor-alpha. Blood Purif 2006;24:174.
47. Malyszko J, Malyszko JS, Koc-Zorawska E, et al. Neutrophil gelatinasea-ssociated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res 2009;32:464.
48. Park JS, Kim GH, Kang CM, et al. Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med 2010;25:77.
49. Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997;43(6 pt 1):1016.
50. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231.
51. Shibata M, Hirota M, Nozawa F, et al. Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy. Cytokine 2000;12:1526.
52. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247.